182 related articles for article (PubMed ID: 12607788)
1. Role of tumor markers in the diagnosis of cystic and intraductal neoplasms.
Hammel P
Gastrointest Endosc Clin N Am; 2002 Oct; 12(4):791-801. PubMed ID: 12607788
[TBL] [Abstract][Full Text] [Related]
2. Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.
O'Toole D; Palazzo L; Hammel P; Ben Yaghlene L; Couvelard A; Felce-Dachez M; Fabre M; Dancour A; Aubert A; Sauvanet A; Maire F; Lévy P; Ruszniewski P
Gastrointest Endosc; 2004 Jun; 59(7):823-9. PubMed ID: 15173795
[TBL] [Abstract][Full Text] [Related]
3. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.
Sperti C; Pasquali C; Guolo P; Polverosi R; Liessi G; Pedrazzoli S
Cancer; 1996 Jul; 78(2):237-43. PubMed ID: 8673998
[TBL] [Abstract][Full Text] [Related]
4. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3.
Bassi C; Salvia R; Gumbs AA; Butturini G; Falconi M; Pederzoli P
Langenbecks Arch Surg; 2002 Nov; 387(7-8):281-5. PubMed ID: 12447553
[TBL] [Abstract][Full Text] [Related]
5. Cyst fluid analysis to diagnose pancreatic cystic lesions: an as yet unfulfilled promise.
Pelaez-Luna M; Chari ST
Gastroenterology; 2006 Mar; 130(3):1007-9; discussion 1009. PubMed ID: 16530543
[No Abstract] [Full Text] [Related]
6. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
Linder JD; Geenen JE; Catalano MF
Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
[TBL] [Abstract][Full Text] [Related]
7. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas.
Hammel P; Levy P; Voitot H; Levy M; Vilgrain V; Zins M; Flejou JF; Molas G; Ruszniewski P; Bernades P
Gastroenterology; 1995 Apr; 108(4):1230-5. PubMed ID: 7535275
[TBL] [Abstract][Full Text] [Related]
8. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.
Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM
Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854
[TBL] [Abstract][Full Text] [Related]
10. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.
van der Waaij LA; van Dullemen HM; Porte RJ
Gastrointest Endosc; 2005 Sep; 62(3):383-9. PubMed ID: 16111956
[TBL] [Abstract][Full Text] [Related]
11. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
[TBL] [Abstract][Full Text] [Related]
12. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
[TBL] [Abstract][Full Text] [Related]
14. The differential diagnosis of pancreatic cysts by MR imaging.
Nishihara K; Kawabata A; Ueno T; Miyahara M; Hamanaka Y; Suzuki T
Hepatogastroenterology; 1996; 43(9):714-20. PubMed ID: 8799419
[TBL] [Abstract][Full Text] [Related]
15. The role of laparoscopy and laparoscopic ultrasound in the diagnosis of cystic lesions of the pancreas.
Schachter PP; Shimonov M; Czerniak A
Gastrointest Endosc Clin N Am; 2002 Oct; 12(4):759-67, vii-viii. PubMed ID: 12607785
[TBL] [Abstract][Full Text] [Related]
16. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
[TBL] [Abstract][Full Text] [Related]
17. Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography.
Sahani D; Prasad S; Saini S; Mueller P
Gastrointest Endosc Clin N Am; 2002 Oct; 12(4):657-72. PubMed ID: 12607778
[TBL] [Abstract][Full Text] [Related]
18. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Pancreatic Cyst Fluid.
Ngamruengphong S; Lennon AM
Surg Pathol Clin; 2016 Dec; 9(4):677-684. PubMed ID: 27926366
[TBL] [Abstract][Full Text] [Related]
20. Cystic fluid chromogranin A levels in different pancreatic cystic lesions.
Oruç N; Aydın A; Barutcuoğlu B; Aktan Ç; Nart D; Veral A
Turk J Gastroenterol; 2015 Nov; 26(6):522-7. PubMed ID: 26510084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
